Genus (LON:GNS) Reaches New 12-Month High - Should You Buy?

Key Points

• Genus plc's share price reached a new 52-week high of GBX 2,485 ($33.57) during mid-day trading.
• Analysts have issued a "buy" rating for Genus, with target prices of GBX 2,750 ($37.15) from Shore Capital and GBX 2,550 ($34.45) from Deutsche Bank.
• The company has a market capitalization of £1.62 billion and operates as an animal genetics company across various global markets.

Genus plc (LON:GNS - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Friday . The company traded as high as GBX 2,485 ($33.57) and last traded at GBX 2,485 ($33.57), with a volume of 3458 shares trading hands. The stock had previously closed at GBX 2,450 ($33.09).

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on GNS shares. Shore Capital reissued a "buy" rating and issued a GBX 2,750 ($37.15) target price on shares of Genus in a research report on Tuesday, July 15th. Deutsche Bank Aktiengesellschaft raised their price target on Genus from GBX 2,250 ($30.39) to GBX 2,550 ($34.45) and gave the company a "buy" rating in a research note on Tuesday, July 15th.

Genus Price Performance

The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The company has a 50 day moving average price of GBX 2,095.48 and a 200 day moving average price of GBX 1,906.15. The company has a market capitalization of £1.62 billion, a P/E ratio of 204.74, a P/E/G ratio of 2.87 and a beta of 0.37.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.